The Scientific Progress Immunoglobulins in Neurology (SPIN) Award Program was launched in 2008 to support research into the use of immunoglobulins in neurology. Grifols proudly supports the SPIN Award Program and believes it demonstrates the company's commitment to innovation in this field of scientific endeavour. We consider the program to be a tangible contribution to the improvement of standards of care and outcomes for patients with neurological conditions.
Application process for the SPIN Award 2021 closed.
The awardee will be announced in June 2021.
Applications for the next edition 2022 will be accepted between 1 August 2021 and 31 January 2022.
To see the 2020 SPIN Award winner
please click here.